Search

Author/Creator Omoruyi, Edmund

1. Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years. (22nd April 2020)

Authors:
Williams, Kristi; Bastian, Arangassery Rosemary; Feldman, Robert Allen; Omoruyi, Edmund; de Paepe, Els; Hendriks, Jenny; van Zeeburg, Hester; Godeaux, Olivier; Langedijk, Johannes P M; Schuitemaker, Hanneke; Sadoff, Jerry; Callendret, Benoit
Journal:
Journal of infectious diseases
Issue:
Volume 222:Number 6(2020)
Page Start:
979
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults. (26th August 2020)

Authors:
Sadoff, Jerald; De Paepe, Els; Haazen, Wouter; Omoruyi, Edmund; Bastian, Arangassery R; Comeaux, Christy; Heijnen, Esther; Strout, Cynthia; Schuitemaker, Hanneke; Callendret, Benoit
Journal:
Journal of infectious diseases
Issue:
Volume 223:Number 4(2021)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Simeprevir and daclatasvir for 12 or 24 weeks in treatment‐naïve patients with hepatitis C virus genotype 1b and advanced liver disease. (13th March 2017)

Authors:
Hézode, Christophe; Almasio, Piero L.; Bourgeois, Stefan; Buggisch, Peter; Brown, Ashley; Diago, Moises; Horsmans, Yves; Serfaty, Lawrence; Szalay, Ferenc; Gaeta, Giovanni B.; Planas, Ramon; Schlag, Michael; Lonjon‐Domanec, Isabelle; Omoruyi, Edmund; DeMasi, Ralph; Zeuzem, Stefan
Journal:
Liver international
Issue:
Volume 37:Number 9(2017)
Page Start:
1304
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗